CTRI/2025/07/091364 [Registered on: 22/07/2025] Trial Registered Prospectively
Last Modified On:
21/07/2025
Post Graduate Thesis
Yes
Type of Trial
Interventional
Type of Study
Homeopathy
Study Design
Single Arm Study
Public Title of Study
Assessment of efficacy of Homoeopathic medicines in Exogenous Eczema.
Scientific Title of Study
Utility of Homoeopathy in cases of Exogenous Eczema.
Trial Acronym
Nil
Secondary IDs if Any
Secondary ID
Identifier
Nil
NIL
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
Name
Divyesh Vijaybhai Parmar
Designation
M D Scholar Part 2
Affiliation
C D Pachchigar College of Homoeopathic Medicine and Hospital
Address
Department of Practice of Medicine of MD second floor C D Pachchigar Homoeopathic Medicine and Hospital Surat Gujarat
Surat GUJARAT 395001 India
Phone
08849952897
Fax
Email
parmardv07@gmail.com
Details of Contact Person Scientific Query
Name
Dr Sameer S Upadhyay
Designation
MD Hom
Affiliation
C D Pachchigar College of Homoeopathic Medicine and Hospital
Address
Department of Practice of Medicine of MD second floor C D Pachchigar Homoeopathic Medicine and Hospital Surat Gujarat
Surat GUJARAT 395001 India
Phone
9426836991
Fax
Email
drsameerupadhyay@rediffmail.com
Details of Contact Person Public Query
Name
Dr Sameer S Upadhyay
Designation
MD Hom
Affiliation
C D Pachchigar College of Homoeopathic Medicine and Hospital
Address
Department of Practice of Medicine of MD second floor C D Pachchigar Homoeopathic Medicine and Hospital Surat Gujarat
Surat GUJARAT 395001 India
Phone
9426836991
Fax
Email
drsameerupadhyay@rediffmail.com
Source of Monetary or Material Support
C D Pachchigar College of Homoeopathic Medicine and Hospital , Udhana magdalla Road , Surat 395001 , Gujarat , India.
Primary Sponsor
Name
C D Pachchigar College of Homoeopathic Medicine and Hospital
Address
C D Pachchigar College of Homoeopathic Medicine and Hospital, Udhana Magdalla Road, Surat , 395001 , Gujarat, India.
Type of Sponsor
Private medical college
Details of Secondary Sponsor
Name
Address
Nil
Nil
Countries of Recruitment
India
Sites of Study
No of Sites = 1
Name of Principal
Investigator
Name of Site
Site Address
Phone/Fax/Email
Divyesh Vijaybhai Parmar
C D Pachchigar College of Homoeopathic Medicine and Hospital
2nd floor, Department Of Practice Of Medicine C D Pachchigar Homoeopathic Medicine and Hospital , Udhana Magdalla Road , Surat 395001 , Gujarat, India. Surat GUJARAT
08849952897
parmardv07@gmail.com
Details of Ethics Committee
No of Ethics Committees= 1
Name of Committee
Approval Status
Institutional Ethical Committee of C.D. Pachchigar College of Homoeopathic Medicine and Hospital
Homoeopathic medicine as per requirement of case in duration of 9 months
Comparator Agent
not applicable
not applicable
Inclusion Criteria
Age From
0.00 Year(s)
Age To
80.00 Year(s)
Gender
Both
Details
patient of all age and both gender
irrespective of all socioeconomic condition and religion are included
cases which are diagnosed clinically according to history sign and symptoms
cases which are previously diagnosed by dermatologist
cases which are diagnosed with laboratory investigation of allergy skin test or patch test
ExclusionCriteria
Details
Cases with irreversible structural changes already developed.
All advanced pathological cases like along with eczema such malignant lesions or advanced pathology developed.
Cases with coexisting severe systemic illness.
Cases with irregular follow up of patient left treatment in between.
Method of Generating Random Sequence
Not Applicable
Method of Concealment
Not Applicable
Blinding/Masking
Not Applicable
Primary Outcome
Outcome
TimePoints
To remove the symptoms of eczema from patient.
9 months
Secondary Outcome
Outcome
TimePoints
To relief the patient from recurring tendency of eczema with Healthy lifestyle.
9 months
Target Sample Size
Total Sample Size="30" Sample Size from India="30" Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials" Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials"
Phase of Trial
Phase 2
Date of First Enrollment (India)
01/08/2025
Date of Study Completion (India)
Applicable only for Completed/Terminated trials
Date of First Enrollment (Global)
Date Missing
Date of Study Completion (Global)
Applicable only for Completed/Terminated trials
Estimated Duration of Trial
Years="0" Months="9" Days="0"
Recruitment Status of Trial (Global)
Not Yet Recruiting
Recruitment Status of Trial (India)
Not Yet Recruiting
Publication Details
N/A
Individual Participant Data (IPD) Sharing Statement
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
Brief Summary
6.2
REVIEWOFLITRATURE:
EXOGENOUSECZEMA
1.Definition:
ThewordeczemaisderivedfromtheGreekword‘eczein’Meaning‘to
boil over’ or ‘to effervesce’. (4)
2.Etiology:
-The
developmentofallergicreactiontoexogenoussubstancesseemsto be the reason of the intrinsic
“sensitizing potency” of the compound and various host factors that determine
susceptibility. Small molecular chemicals vary in their potential to induce
allergic sensitivity: primly can sensitize most people, nickel sensitizes
10-20% of women, while many other agents sensitize a smaller minority. The
sensitizing potency of a chemical is thought to be related to its chemical
reactivity and ability to bindtoproteins,whichactas“carriers,”facilitatingthepresentationofthe
substance to the immune system. Host susceptibility is related to as yet
uncharacterize genetic factors, which include variation in metabolic pathways
that handle exogenous eczema. (5)
4.ClassificationofEczema:
-Dependingupontheclinicalmanifestations,eczemacanbesubdivided into the following three
stages:
-Acute
Eczema: It represents wet dermatitis characterized by
intense pruritus,erythema,edema,papules,vesicles,oozing,crusting,andeven blister formation.
-SubacuteEczema:Itischaracterizedbydiffuseerythema,edemaand scaling. In this stage, edema,
vesiculation and oozing components comedown. The lesion starts scaling.
-Chronic Eczema: It is
represented by severe itching, hyperkeratosis andlichenification(thickening,hyper-pigmentationandaccentuatedskin markings).
(4)
5.Causes of Exogenous Eczema: can be broadly divided
into irritant substances that have a direct effect on the skin and allergic
chemicals with which dermatitis follows delayed type IV cell-mediated
hypersensitivity reactions.
-When skin sensitizers penetrate the epidermis, they
are taken up by Langerhans’ cells—bone marrow-derived members of the macrophage
family that function as “professional antigen presenting cells.” The
Langerhans’ cells leave the epidermis and migrate to the regionallymph nodes, where they enter the
paracortical areas, the home of naive T lymphocytes. Probably while en route to
the lymph node, the Langerhans’ cells process the sensitizer so it is
physically associated with the HLA-DR molecules on the cell surface. In the
node, the Langerhans’ cells “present” the sensitizer to T lymphocytes of the
immune system. If T cells with the appropriate specific receptor recognize the
complex of sensitizer and HLA-DR, they proliferate to establish “immunological
memory.” The memory T cells that mediate allergic contact eczema are of the Th1
subtype, characterized by the production of interleukin 2 and interferon gamma.
The induction of sensitization and establishment of immunological memory takes
8-14 days. Should re-exposure to the sensitizer occur, Langerhans’ cells carry
it down into the dermis, where they present it to memory T cells travelling
through the tissues and These are activated to release cytokines (including
interferon gamma) that attract other cells and activate vascular responses,
resulting in the characteristic inflammation of contact eczema.(9)
7.Clinical
features:
-Contact dermatitis: contactdermatitisis an inflammatory skin process caused by an exogenous agents or
agents that directly or indirectly injure the skin. Contact eczema develops as
result of contact with injurious materials. These materials may injure by
direct toxins actions (irritants) or may induce immunological reaction of
delayed hypersensitivity reaction (allergens).
-Irritant contact dermatitis: Any physical or
chemical agent that is capable of producing, if applied for sufficient time and
in sufficient concentration can lead to irritant dermatitis. Dermatitis occurs
when the repair capacity of the skin is exhausted or when the penetration of chemicals
excites an inflammatory response. This type of dermatitis occurs due to contact
with irritants like detergents, acids, alkaline chemicals, oils, organic
solvents, oxidants, and reducing agents. The intensity of the inflammation is
related to the concentration of irritant and the exposure time. Mild irritants
cause dryness, fissuring and erythema (cumulative irritant dermatitis; wear and
tear dermatitis) and strong irritants may produce an immediate reaction
characterized by burning, erythema, edema, blistering, and possibly ulceration
of skin Housewife‘s eczema, diaper dermatitis and industrial dermatitis are
commonexamples of cumulative
irritant contact dermatitis. Housewife‘s dermatitis and industrial/occupational
dermatitis commonly affect the hands. Treatment of acute irritant dermatitis
requires washing quickly with water or a weak neutralizing solution or frequent
wet compresses, followed by the application of a bland or antibacterial with
mid-potency steroid cream. For chronic cases, removal of all adverse chemical
and physical factors and the use of bland barrier cream and mid potency topical
steroids are necessary along with protective gloves. (5)
-Allergic Contact Dermatitis: ACD is a
manifestation of delayed type hypersensitivity mediated by memory T lymphocytes
in the skin. Prior exposure to the offending agent is necessary to develop the
hypersensitivity reaction, which may take as little as 12 h or as longas 72 h to develop. The most common cause
of ACD is exposure to plants, especially to members of the family
Anacardiaceae, including the genus Toxicodendron. Poison ivy, poison oak,
and poison sumac are members of this genus and cause an allergic reaction
marked by erythema, vesiculation, and severe pruritus. The eruption is often
linear or angular, corresponding to areas where plants have touched the skin.
(6)
-Parthenium dermatitis is the most
common and severe type of allergic contact dermatitis seen in India. It is
caused by a weed Parthenium hysterophorus which grows wild
along roads, railway tracks and in the fields. It commonly manifests as
air-borne contact dermatitis affecting mainly the face including the eyelids,
neck, flexures of the extremities, and sometimes the whole body surface may be
involved. Distribution of lesions on sun-exposed areas is not uncommon. There
is worsening during summer and rainy season while the lesions undergo partial
or complete remission during winter.
-Nickel sensitivity
is quite common and manifests as dermatitis due toear rings, bangles, necklace, zips, metal buttons, and safety
pins. Occupational nickel sensitivity affects the hands. Chromium allergy is
also quite common and is usually due to leather footwear, cement etc.
Leather is the
most common causes. Topical medicament dermatitis is commonly due to
nitrofurazone and neomycin. Neomycin sensitivity is quite often superimposed on
varicose and footwear eczema, andremains
undetected due to its use with topical steroids.Hair dye dermatitis are also
not uncommon and it’s becoming common due tohigh concentrations of paraphenylenediamine (PPD) in Kali Mehndi (black
henna). Other types of allergic contact dermatitis peculiar in our country are
bindi dermatitis. Black henna dermatitis and tooth powder dermatitis.The commonallergensin India
aremetals(nickel,chromium),
rubber chemicals (mercaptobenzothiazole), Parthenium (a weed), medicaments
(nitrofurazone, neomycin) and hair dye (PPD). (4)
7.INVESTIGATIONS:
Although
clinical examination is quite sufficient to suggestthe diagnosisofeczema,asa generalrule itisadvisable to treat acute
eczemas without investigations. On the other hand, chronic and recurrent
eczemas shouldbeinvestigated thoroughly tofind the cause of eczema.
-Patch Testing: It is the only scientific
method available to confirm the diagnosisof
allergiccontact dermatitisbutisnot useful forirritant contact dermatitis as it detects the allergens
responsible for type IV allergy only. It should be performed after the acute
stage subsides. A series of allergens in adequate concentration are applied on
the back with adhesive tape and left on for 2 days. The readings are taken on
day 2 and day 4. The offending allergens will produce erythema and
papulovesicles at the site of application. A good patch test should indicate
contact sensitization and produce no false positive reactions.
-Photopatch Testing: These tests are
performed to find the cause of photo allergic contact dermatitis. It should be
performed in photo distributed dermatitis. In photopatch testing also, the
patches of chemicals are applied as for ordinary patch testing, except that
they are applied in duplicate and after 24 hours one set of patches is removed
and the under lying skin is irradiated with ultraviolet light. Afterirradiation, the patch sites are covered
again and evaluated at day 2 and day 4.
-Prick Testing: These
are performed to detect the type I hypersensitivity reactions. Relevance of
positive prick tests in establishing the cause of the eczema is questionable.
-Serological Testing: Estimation of
total serum IgE and IgE antibodies specific to certain antigens are useful
diagnostic criteria for atopic dermatitis. Radio-allergosorbent test (RAST) is
helpful to detect specific dietary environmental allergens, which could be
aggravating the dermatitis.
-Skin Biopsy: A
skin biopsy is rarely required to diagnose the eczema andhistopathologicalfindingswilldependuponthestage.(4)
8.TREATMENT: Successful
management of dermatitis requires a multipronged approach. Apart from the
specific therapy, appropriate general measures are very helpful in treating the
eczemas.
-GENERAL MEASURES: Identification of any
offending allergen, irritant or triggering factor is very important. Adequate
measures to avoid the offenders may help in treating the dermatitis. Eczemas
like atopic dermatitis and Asteatotic dermatitis are associated with dry skin
and hence increased susceptibility to irritants. Maintaining proper hydrationof the skin is important in treating dry
eczema.
-Topical Treatment: Wet compresses
with a solution of either potassium permanganate (0.01%/light pink color) or
aluminum sulphate (0.65%) followed by application ofsteroid lotion cream isbestin the oozing stage of eczema. These
compresses help by suppressing inflammation, removal of crusts, have
antibacterial action and cause drying of the lesions. In the sub acute stage,
wet compresses should be discontinued and only mid-potency topical steroid
cream can be prescribed. Chronic eczema requires potent steroid in ointment base
for topical application.In
lichenified lesions, a topical steroid can be combined with keratolytic agents
like salicylic acid or urea. For secondary bacterial infection a topical
antibiotic can be combined with a steroid.
-Systemic Treatment A short course of
systemic steroids may beneeded for
extensive lesions and when an irritant dermatitis eruption (spread of an acute
inflammatory dermatitis to distant sites is termed irritant dermatitis eruption
or autosensitisation) develops in acute eczema. Systemic antibiotics are
required for infected lesions. Oral antihistamines may beprescribed,as andwhenrequired,but maynotbe helpful in contact dermatitis. Steroid
sparing agents like methotrexate in small weekly doses, azathioprine, and even
cyclosporine may be required in recalcitrant cases like atopic dermatitis,
Parthenium dermatitis, etc. (4)
9.Homeopathic Approach: Some
of homoeopathic remedy which are much important for treatment of exogenous
eczema from source book like.HomoeopathicTherapeuticsbyDr.SamuelLilienthal and Boericke’s New Manual of Homoeopathic Materia Medica and
Allen’s keynotes are as under.
1.Mezereum: Eczema
intolerable itching, chillyness with pruritus, worse in bed, eruptions
ulcerated and form thick scabs under purulent matter exudates (7) eczema and
itching eruptions after vaccination, eruptions moist, itching worse at night
(8) eruptions with itching and pustules, followed by desquamation (9)
2.Graphites: Rough,
hard, persistent dryness of skin unaffected by eczema, eruptions oozing out
sticky exudation (7) unhealthy skin,
Eruptionsmoistandfissured,uponerasbetweenfingersandtoes,oozes
Watery, transplant and sticky fluids (8)
3.Sulphur:skinitchingvoluptuous;scratching>feelsgoodtoscratchbut causing burning,scratching << from eatofbed
(8) skin affections after local medication, itching, burning worse scratching
and washing (7) sequel of suppressed eruptions, itching with soreness after
scratching (9)
5.Antimoniumcrudum:eczemawithgastricderangements,vesiclesand pustules,
thick hard honey colored scabs (7) suppressed eruptions, disposition to
abnormal growth of skin (8) eczema of nostril, sub acute eczema about mouth,
eruptions burning and itching worse at night (10)
7.Arsenicum
iodum: eczema of beard, watery, oozing, itching worse washing ,marked
exfoliation of skin large scales , dry, scaly itching eruptions(7)eruptiononfaceandextremities,withcorrosivedischarge (9)
8.CistusCanadensis:skinofhandshard,thick,dry,fissured;deep cracks (7) itching all over body,
vesicular erysipelas of face (10)
9.Thuja occidentalis: itching vesicles, with
shooting pains, burning violentlyafterscratching,scalyeruptiononhandsextendingtotemples, eyebrows, ears and
neck (9) eruptions only on covered parts, painful sensitiveness of skin,
smelling like a old cheese (10)
10.Sepia officinalis: dry and itching eruptions
like scabies, bad effects whereitchhasbeensuppressedbymercury,excoriationesp.injoints
(10)dryoffensiveeruptionsonvertex,backofhands,prurituswith vesicles on
acrid base all over the part of the body (9)
11.Oleander : vesicular
eruption about head of children, with smooth shinning surface, with drops of
serum standing out here and there, humid scaly eruptions on the back part of
the head, skin gets raw by rubbingoftheclothing(9)gnawingitching,whichcompelsscratching, sometimes when undressing (10)
6.3
OBJECTIVESOFTHESTUDY:
1.Tostudyexogenouseczemaetiology,clinicalpresentation and management (medicinal and lifestyle
management).
2.Toknowtheroleofhomoeopathicmedicineintreatmentand management of exogenous eczema.
3.Study population – cases having
complained of eczema treated with homoeopathic medicine at C.D. Pachchigar
College of Homoeopathic Medicine and Hospital.
1.Improvement:patientrelievedfrompresentingcomplaintinfrequency and in
intensity.
2.Noimprovement:patientwhodidn’tgetanyreliefinspiteofgiving
medicines at regular interval.
-Followupcaseswill bedoneatevery7,15,21,30daysasperrequirement of case.
7.4
DOES THE STUDY REQUIRING ANY
INVESTIGATIONTOBE CONDUCTED ON PATIENTS OR OTHER HUMANSORANIMALS?
Asperrequirementofthecase
7.5
HAS ETHICAL CLEARENCE BEEN OBTAINEDFROMYOUR INSTITUTE?
YES
8BIBLIOGRAPHY:
1.
JunoJ.JoelNJSCSea.PatternsofSkinDiseaseandPrescribingTrendsin Rural India. Sch. Acad. J. Pharm. 2013; 2(4): 304-309.
2.
al.
SRe. Study of prescribing pattern of topical corticosteroids in the
departmentofdermatologyinmultispecialtytertiarycareteachinghospital in south India.
Inj.J.Res.Pharm.Sci. 2012; 3(4): 685-687.
3.
SwamyAV,KAS,BLN.Epidemiologicalprofileandclinicalpatternof aropic dermatitis in South Indian teaching Innovative Education And
Scientific Research Foundation. IP Indian journal of Clinical and
Experimental Dermatology. 2019; 5(2): 146-153.
4.
MunjalYP.APITextbookofMedicine.9thed.Munjal`YP,editor.Mumbai: The Association of Physicians of
India; 2012.
5.
Golwalla
AF. Golwalla’s MEDICINE for students A reference book for the familyphysician.25thed.NadkarMY,editor.NewDelhi:JaypeeBrothers. Medical Publishers (P) Ltd.; 2017.
6.
L,Fauci,Kasper,Hauser,Longo,Jameson.HARRISON’SPRINCIPLES OF INTERNAL MEDICINE. 21st ed.: Mc Graw Hill; 2022.
SamuelL.HOMOEOPATHICTHERAPEUTICS.Reprinteditioned.New Delhi: Indian books
& Periodicals Publishers; 2006.
9.
Boericke W. BOERICKE’SNew Manual Of Homoeopathic MATERIA
MEDICAWithRepertory.thirdrevised&augmentededitionbasedon Ninth Edition ed.
Noida: B. JAIN PUBLISHERS (P) LTD.; 2021.
10.
AllenHC.Kerynotesandcharacteristicswithcomparisionsofsomeofthe
leading remedies of the Materia Medica with bowel nosode. 8th ed.: B. Jain
Publisher; 2008.